Group 1 - The controlling shareholder of Guanzhong Ecological plans to change to Deep Blue Financial Whale, with resumption of trading on September 29 [1] - Zengsheng Technology's controlling shareholder intends to reduce its stake by no more than 3% [1] - Fengyuzhu's shareholder plans to reduce its stake by no more than 3% [1] - Zhonghuan Environmental Protection is planning a change of control and has suspended trading [1] - Nanjing Pharmaceutical's subsidiary, Guangyao Phase II Fund, is acquiring 11.04% of the company's shares [1] - Hailianxun has received approval from the CSRC for a stock swap merger with Hangqilun [1] Group 2 - Jinggong Convertible Bond and Kangyi Convertible Bond will not undergo adjustments [2] - Various convertible bonds are listed with their current prices, redemption prices, last trading days, last conversion days, conversion values, remaining scales, and the proportion of convertible bonds to the underlying stocks [4][6]

Key Points - The company announced an adjustment to the conversion price of its convertible bonds, "Kangyi Convertible Bonds," from 27.80 yuan/share to 27.55 yuan/share due to a cash dividend distribution [5] - The total amount of cash dividends to be distributed is 100,450,744.25 yuan, with a distribution of 2.5 yuan for every 10 shares [4] - The initial conversion price of the bonds was set at 28.22 yuan/share when they were issued, and the bonds were first listed on July 20, 2022 [1][2] - The adjustment formula for the conversion price is based on various corporate actions such as stock dividends, capital increases, and cash dividends [1][2] - The adjusted conversion price will take effect from May 30, 2025, which is the ex-dividend date [5]

Group 1 - The core viewpoint of the article discusses various corporate actions related to convertible bonds and stock control changes, indicating a dynamic environment in the investment landscape [1] Group 2 - Haoke Convertible Bond is approaching a down adjustment [1] - Xizi Clean Energy's subsidiary plans to sign a relocation compensation agreement worth 274 million yuan [1] - Kesu Convertible Bond is subject to strong redemption [1] - Xuelong Biological's controlling shareholder is planning a change in company control, leading to a stock suspension [1] - Kangyi Convertible Bond will not undergo a down adjustment [1]